Form 4: Delek US Holdings CFO Reuven Spiegel Reports Stock Transactions
SEC Form 4 Filing
Reuven Spiegel, CFO of Delek US Holdings, reports the disposition of shares to cover tax obligations and a sale under a pre-arranged 10b5-1 trading plan.
Summary
- On June 10, 2024, Reuven Spiegel, CFO of Delek US Holdings, reported transactions involving the company's common stock.
- 2,026 shares were disposed of to cover tax obligations at a price of $24.88 per share.
- Additionally, 750 shares were sold at $24.14 per share under a pre-arranged 10b5-1 trading plan adopted on August 10, 2023.
- Following these transactions, Spiegel directly owns 50,456 shares of Delek US Holdings.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports routine stock transactions by an executive. The use of a 10b5-1 plan suggests the transactions were pre-planned and not based on any recent non-public information.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on any recent non-public information.
Comparison to Industry Standards
- Form 4 filings are a standard part of corporate governance and are required by the SEC.
- The use of a 10b5-1 trading plan is a common practice among corporate executives to avoid accusations of insider trading.
- Comparable companies such as Marathon Petroleum, Valero Energy, and Phillips 66 also have executives who utilize 10b5-1 plans for stock transactions.
Stakeholder Impact
- The transactions are unlikely to have a significant impact on stakeholders as they are routine and pre-planned.
Key Dates
| Date | Description |
|---|---|
| 08/10/2023 | Date of adoption of the 10b5-1 trading plan. |
| 06/10/2024 | Date of the reported stock transactions (disposition of shares for tax obligations and sale under 10b5-1 plan). |
| 06/12/2024 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.